ADMA Shareholder Alert: ADMA Biologics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm

The Gross Law Firm issued a notice encouraging ADMA Biologics (NASDAQ: ADMA) shareholders who bought during the class period to contact the firm about appointing a lead plaintiff. This suggests an ongoing shareholder litigation effort, which can create headline risk and modest valuation uncertainty for the stock even though no financial figures or outcomes are disclosed.

Analysis

The Gross Law Firm issued a notice encouraging ADMA Biologics (NASDAQ: ADMA) shareholders who bought during the class period to contact the firm about appointing a lead plaintiff. This suggests an ongoing shareholder litigation effort, which can create headline risk and modest valuation uncertainty for the stock even though no financial figures or outcomes are disclosed.